Bank of America’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34
Closed -$614 6257
2025
Q4
$614 Hold
34
﹤0.01% 6536
2025
Q3
$1.02K Buy
34
+5
+17% +$149 ﹤0.01% 7494
2025
Q2
$858 Hold
29
﹤0.01% 7565
2025
Q1
$1.01K Hold
29
﹤0.01% 7420
2024
Q4
$948 Hold
29
﹤0.01% 7299
2024
Q3
$526 Hold
29
﹤0.01% 7370
2024
Q2
$638 Hold
29
﹤0.01% 7308
2024
Q1
$1.03K Sell
29
-883
-97% -$34.5K ﹤0.01% 7201
2023
Q4
$29.3K Hold
912
﹤0.01% 6716
2023
Q3
$14.8K Sell
912
-165
-15% -$5.19K ﹤0.01% 6777
2023
Q2
$37.5K Buy
1,077
+157
+17% +$5.62K ﹤0.01% 6546
2023
Q1
$31.7K Sell
920
-926
-50% -$34.4K ﹤0.01% 6630
2022
Q4
$85.9K Buy
1,846
+672
+57% +$24.1K ﹤0.01% 6284
2022
Q3
$45K Buy
1,174
+287
+32% +$14.2K ﹤0.01% 6720
2022
Q2
$45K Sell
887
-10
-1% -$602 ﹤0.01% 6884
2022
Q1
$64K Sell
897
-69
-7% -$5.35K ﹤0.01% 7068
2021
Q4
$88K Buy
966
+215
+29% +$35.9K ﹤0.01% 6936
2021
Q3
$198K Buy
+751
New +$223K ﹤0.01% 6320

Other funds holding ICCM

Bank of America's ICCM Position: Q1 2026 in Review

Bank of America sold out of IceCure Medical (ICCM) in Q1 2026, closing a stake of 34 shares — an estimated $614 sold.

Bank of America first reported a position in ICCM in Q3 2021 and held it in 18 quarters. The position peaked at $198K in Q3 2021. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

  • Bank of America reported no remaining IceCure Medical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 34 IceCure Medical shares in Q1 2026, an estimated $614.
  • Bank of America first reported a position in IceCure Medical in Q3 2021 and held it in 18 quarters.
  • Bank of America's IceCure Medical position peaked at $198K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.